CompletedEUCTR 2005-005597-67
An eight-week, double-blind placebo controlled, multicenter study evaluating the efficacy, safety, tolerability of a fixed dose of SR58611A (350 mg q12) in elderly patients with Major Depressive Di...
This historical record does not confirm current site availability.
Historical research recordFinland + SlovakiaDepression
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Finland · Slovakia
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateNot clearly listed
- Recruitment status
- Completed
- Enrollment listed in the registry
- 280
- Sponsor
- sanofi-aventis recherche & développement
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- Finland, Slovakia
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2005-005597-67
- Official title
Show the full official title
An eight-week, double-blind placebo controlled, multicenter study evaluating the efficacy, safety, tolerability of a fixed dose of SR58611A (350 mg q12) in elderly patients with Major Depressive Di...
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedFinland · Slovakia
Questions about this study
Who is behind this study?
The study sponsor is sanofi-aventis recherche & développement.
